Nextleaf Solutions Ltd. (OILS.CN)
CAD 0.06
(0.0%)
CAD 0.06
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.14 Million CAD | 136.53% |
| 2022 | -1.94 Million CAD | 45.0% |
| 2021 | -3.79 Million CAD | 20.21% |
| 2020 | -5.04 Million CAD | 11.26% |
| 2019 | -8.51 Million CAD | -182.52% |
| 2018 | -1.89 Million CAD | -9436.32% |
| 2017 | -122.65 Thousand CAD | 255.84% |
| 2016 | - CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | -127.9 Thousand CAD | 84.18% |
| 2024 Q2 | -823.4 Thousand CAD | -341.19% |
| 2024 Q1 | 335.17 Thousand CAD | -44.57% |
| 2023 Q2 | 187.9 Thousand CAD | 150.49% |
| 2023 Q1 | -372.16 Thousand CAD | 45.47% |
| 2023 FY | - CAD | 136.53% |
| 2023 Q4 | 249.43 Thousand CAD | -59.48% |
| 2023 Q3 | 615.54 Thousand CAD | 227.59% |
| 2022 Q4 | -682.49 Thousand CAD | 11.93% |
| 2022 Q3 | -774.96 Thousand CAD | -260.5% |
| 2022 Q2 | -214.96 Thousand CAD | 48.48% |
| 2022 Q1 | -417.21 Thousand CAD | 71.11% |
| 2022 FY | - CAD | 45.0% |
| 2021 FY | - CAD | 20.21% |
| 2021 Q2 | -1.1 Million CAD | -89.24% |
| 2021 Q3 | -286.06 Thousand CAD | 74.14% |
| 2021 Q4 | -1.44 Million CAD | -404.75% |
| 2021 Q1 | -584.55 Thousand CAD | 58.97% |
| 2020 Q4 | -1.42 Million CAD | -36.63% |
| 2020 Q1 | -1.1 Million CAD | -225.49% |
| 2020 Q2 | -1.19 Million CAD | -7.92% |
| 2020 FY | - CAD | 11.26% |
| 2020 Q3 | -1.04 Million CAD | 12.43% |
| 2019 Q3 | -1.48 Million CAD | 62.9% |
| 2019 FY | - CAD | -182.52% |
| 2019 Q4 | 879.27 Thousand CAD | 159.12% |
| 2019 Q2 | -4 Million CAD | -32724.22% |
| 2019 Q1 | 12.28 Thousand CAD | 144.12% |
| 2018 Q1 | -21.02 Thousand CAD | 52.0% |
| 2018 Q2 | 65.53 Thousand CAD | 411.75% |
| 2018 FY | - CAD | -9436.32% |
| 2018 Q3 | -6992.00 CAD | -110.67% |
| 2018 Q4 | -27.85 Thousand CAD | -298.31% |
| 2017 FY | - CAD | 255.84% |
| 2017 Q3 | -22.8 Thousand CAD | 0.0% |
| 2017 Q4 | -43.8 Thousand CAD | -92.08% |
| 2016 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aion Therapeutic Inc. | -6.07 Million CAD | 118.796% |
| Ayurcann Holdings Corp. | -2.01 Million CAD | 156.782% |
| Blueberries Medical Corp. | -1.22 Million CAD | 193.437% |
| The BC Bud Corporation | -1.19 Million CAD | 195.45% |
| BioNxt Solutions Inc. | -6.48 Million CAD | 117.605% |
| CordovaCann Corp. | -1.6 Million CAD | 171.234% |
| Christina Lake Cannabis Corp. | -2.62 Million CAD | 143.515% |
| Captor Capital Corp. | 2.42 Million CAD | 52.849% |
| City View Green Holdings Inc. | -2.01 Million CAD | 156.67% |
| 1CM Inc. | 1.31 Million CAD | 13.089% |
| Global Hemp Group Inc. | -24.79 Thousand CAD | 4704.53% |
| Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | 151.694% |
| IM Cannabis Corp. | -2.79 Million CAD | 140.918% |
| Lobe Sciences Ltd. | -4.4 Million CAD | 125.932% |
| Maple Leaf Green World Inc. | -392.21 Thousand CAD | 391.064% |
| Mountain Valley MD Holdings Inc. | -3.19 Million CAD | 135.753% |
| Ovation Science Inc. | -778.83 Thousand CAD | 246.579% |
| Pharmadrug Inc. | -1.33 Million CAD | 185.512% |
| Captiva Verde Wellness Corp. | -6.05 Million CAD | 118.85% |
| RAMM Pharma Corp. | -6.3 Million CAD | 118.115% |
| RIV Capital Inc. | -20.28 Million CAD | 105.629% |
| Revive Therapeutics Ltd. | -5.59 Million CAD | 120.404% |
| Red White & Bloom Brands Inc. | -77.59 Million CAD | 101.471% |
| SLANG Worldwide Inc. | -2.95 Million CAD | 138.689% |
| 1933 Industries Inc. | -10.03 Million CAD | 111.379% |
| Red Light Holland Corp. | -5.25 Million CAD | 121.721% |
| Top Strike Resources Corp. | -767.99 Thousand CAD | 248.647% |
| Xebra Brands Ltd. | -1.49 Million CAD | 176.361% |
| Adastra Holdings Ltd. | -1.41 Million CAD | 180.892% |